Abstract
The modern era of investigation of human cytomegalovirus (HCMV) began with the independent isolation of viruses from three different laboratories(1–3) An insightful historic account of those reports was given by Weller.(4) The AD 169 strain isolated by Rowe et al.(3) from cultures of adenoids and the Davis strain isolated by Weller et al.(2) from a liver biopsy became prototype strains for study. More recently, the Towne strain isolated from urine and studied by Plotkin et al.(5) as a vaccine candidate joined AD 169 and Davis as the three most studied strains of HCMV.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Smith, M. G., Propagation in tissue cultures of a cytopathogenic virus from human salivary gland virus (SGV) disease, Proc. Soc. Exp. Biol. Med. 92:424–430 (1956).
Weller, T. H., J. C. Macauley, J. M. Craig, and P. Wirth, Isolation of intranuclear inclusion producing agents from infants with illnesses resembling cytomegalic inclusion disease, Proc. Soc. Exp. Biol. Med. 94:4–12 (1957).
Rowe, W. P., J. W. Hartley, S. Waterman, H. C. Turner, and R. J. Huebner, Cytopath ogenic agent resembling human salivary gland virus recovered from tissue cultures of human adenoids, Proc. Soc. Exp. Biol. Med. 94:418–424 (1956).
Weller, T. H., Cytomegalovirus: The difficult years, J. Infect. Dis. 122:532–539 (1970).
Plotkin, S. A., T. Furukawa, N. Zygraich, and C. Huygelen, Candidate cytomegalovirus strain for human vaccination, Infect. Immun. 12:521–527 (1975).
Ho, M., Congenital and perinatal human cytomegalovirus infections, in: Cytomegalovirus, Biology and Infection: Current Topics in Infectious Diseases (W. B. Greenough III and T. C. Merigan, eds.), pp. 131–149, Plenum, New York (1982).
Griffiths, P. D., A. Campbell-Benzie, and R. B. Heath, A prospective study of cytomegalovirus infection in pregnant women, Br. J. Obstet. Gynecol. 87:308–314 (1980).
Grant, S., E. Edmond, and J. Syme, A prospective study of cytomegalovirus infection in pregnancy. I. Laboratory evidence of congenital infection following maternal primary and reactivated infection, J. Infect. 3:24–31 (1981).
Stagno, S., R. F. Pass, M. E. Dworsky, R. E. Henderson, E. G. Moore, P. D. Walton, and C. A. Alford, Congenital cytomegalovirus infection. The relative importance of primary and recurrent maternal infection, N. Engl. J. Med. 306:945–949 (1982).
Melish, M. E., and J. B. Hanshaw, Congenital cytomegalovirus infection: Developmental progress of infants detected by routine screening, Am. J. Dis. Child. 126:190–194 (1973).
Saigal, S., O. Lunyk, R. P. B. Larke, and M. A. Chernesky, The outcome in children with congenital cytomegalovirus infection: A longitudinal follow-up study, Am. J. Dis. Child. 136:896–901 (1982).
Kumar, M. L., G. A. Nankervis, I. B. Jacobs, C. B. Ernhart, C. E. Glasson, P. M. McMillan, and E. Gold, Congenital and postnatally acquired cytomegalovirus infections: Long-term follow-up, J. Pediatr. 104:674–679 (1984).
Reynolds, D. W., S. Stagno, K. G. Stubbs, A. J. Dahle, M. M. Livingston, S. S. Saxon, and C. A. Alford, Jr., Inapparent congenital cytomegalovirus infection with elevated IgM levels: Causal relationship with auditory and mental deficiency, N. Engl. J. Med. 290:291–296 (1974).
Nankervis, G. A., M. L. Kumar, F. E. Cox, and E. Gold, A prospective study of maternal cytomegalovirus infection and its effect on the fetus, Am. J. Obstet. Gynecol. 149:435–440 (1984).
Ahlfors, K., M.Forsgren, S.-A. Ivarsson, S. Harris, and L. Svanberg, Congenital cytomegalovirus infection on the relation between type and time of maternal infection and infant’s symptoms, Scand. J. Infect. Dis. 15:129–138 (1983).
Monif, G. R. G., E. A. Egan, II, B. Held, and D. V. Eitzman, The correlation of maternal cytomegalovirus infection during varying stages in gestation with neonatal involvement, J. Pediatr. 80:17–20 (1972).
Stern, H., and S. M. Tucker, Prospective study of cytomegalovirus infection in pregnan cy, Br. Med. J. 2:268–270 (1973).
Stagno, S., D. W. Reynolds, E. S. Huang, S. D. Thames, R. J. Smith, and C. A. Alford, Jr., Congenital cytomegalovirus infection: Occurrence in an immune population, N. Engl. J. Med. 296:1254–1258 (1977).
Schopfer, K., E. Laube, and U. Krech, Congenital cytomegalovirus infection in newborn infants of mothers infected before pregnancy, Arch. Dis. Child. 53:536–539 (1978).
Stagno, S., D. W. Reynolds, A. Tsiantos, D. A. Fuccillo, W. Long, and C. A. Alford, Jr., Comparative serial virologic and serologic studies of symptomatic and subclinical congenitally and naturally acquired cytomegalovirus infections, J. Infect. Dis. 132:568–577 (1975).
Stagno, S., M. E. Dworsky, J. Tores, T. Mesa, and T. Hirsh, Prevalence and importance of congenital cytomegalovirus infection in three different populations, J. Pediatr. 101:897–900 (1982).
Reynolds, D. W., P. H. Dean, R. F. Pass, and C. A. Alford, Jr., Specific cell-mediated immunity in children with congenital and neonatal cytomegalovirus infection and their mothers, J. Infect. Dis. 140:493–499 (1979).
Starr, S. E., M. D. Tolpin, H. M. Friedman, K. Pauker, and S. A. Plotkin, Impaired cellular immunity to cytomegalovirus in congenitally infected children and their mothers, J. Infect. Dis. 140:500–505 (1979).
Pass, R. F., S. Stagno, W. J. Britt, and C. A. Alford, Specific cell-mediated immunity and the natural history of congenital infection with cytomegalovirus, J. Infect. Dis. 148:953– 961 (1983).
Okabe, M., S. Chiba, T. Tamura, Y. Chiba, and T. Nakao, Longitudinal studies of cytomegalovirus-specific cell-mediated immunity in congenitally infected infants, Infect. Immun. 41:128–131 (1983).
Reynolds, D. W., S. Stagno, T. S. Hosty, M. Tiller, and C. A. Alford, Jr., Maternal cytomegalovirus excretion and perinatal infection, N. Engl. J. Med. 289:1–5 (1973).
Kumar, M. L., E. Gold, and G. A. Nankervis, Risk of acquired cytomegalovirus infection in infants of maternal CMV excretors, Pediatr. Res. 9:512, 1975.
Stagno, S., D. W. Reynolds, R. F. Pass, and C. A. Alford, Jr., Breast milk and the risk of cytomegalovirus infection, N. Engl. J. Med. 302:1073–1074 (1980).
Numazaki, Y., N. Yano, T. Morizuka, S. Takai, and N. Ishida, Primary infection with human cytomegalovirus: Virus isolation from healthy infants and pregnant women, Am. J. Epidemiol. 91:410–417 (1970).
Reynolds, D. W., S. Stagno, R. Reynolds, and C. A. Alford, Jr., Perinatal cytomegalovirus infection: influence of placentally transferred maternal antibody, J. Infect. Dis. 137:564–567 (1978).
Ballard, R. B., W. L. Drew, K. G. Hufnagle, and P. A. Riedel, Acquired cytomegalovirus infection in pre-term infants, Am. J. Dis. Child. 133:482–485 (1979).
Yeager, A. S., P. E. Palumbo, N. Malachowski, R. L. Ariagno, and D. K. Stevenson,Sequelae of maternally derived cytomegalovirus infections in premature infants, J. Pediatr. 102:918–922 (1983).
Klemola, E., R. von Essen, G. Henle, and W. Henle, Infectious-mononucleosis-like disease with negative heterophile agglutination test. Clinical features in relation to Epstein-Barr virus and cytomegalovirus antibodies, J. Infect. Dis. 121:608–614 (1970).
Ho, M., Human cytomegalovirus infections in immunosuppressed patients, in: Cytomeg alovirus, Biology and Infection: Current Topics in Infectious Diseases (W. B. Greenough III and T. C. Merigan, eds.), pp. 171–201, Plenum, New York (1982).
Dowling, J. N., A. R. Saslow, J. A. Armstrong, and M. Ho, Cytomegalovirus infection in patients receiving immunosuppressive therapy for rheumatologic disorders, J. Infect. Dis. 133:399–408 (1976).
Pass, R. F., D. W. Reynolds, J. D. Whelchel, A. G. Diethelm, and C. A. Alford, Impaired lymphocyte transformation response to cytomegalovirus and phytohemagglutinin in recipients of renal transplants: Association with antithymocyte globulin, J. Infect. Dis. 143:259–265 (1981).
Sarov, I., and I. Abody, The morphogenesis of human cytomegalovirus. Isolation and polypeptide characterization of cytomegalovirions and dense bodies, Virology 66:464–473 (1975).
Kim, K. S., V. Sapienza, R. I. Carp, and H. M. Moon, Analysis of structural polypeptides of purified human cytomegalovirus, J. Virol. 20:604–611 (1976).
Stinski, M. F., Synthesis of proteins and glycoproteins in cells infected with human cytomegalovirus, J. Virol. 23:751–767 (1977).
Stinski, M. F., Human cytomegalovirus: Glycoproteins associated with virions and dense bodies, J. Virol. 19:594–609 (1976).
Farrar, G. H., and J. D. Oram, Characterization of human cytomegalovirus envelope glycoproteins, J. Gen. Virol. 65:1991–2001 (1984).
Furukawa, T., A. Fioretti, and S. A. Plotkin, Growth characteristics of cytomegalovirus in human fibroblasts with demonstration of protein synthesis early in viral replication, J. Virol. 11:991–997 (1973).
Stinski, M. F., Sequence of protein synthesis in cells infected by human cytomegalovirus: Early and late virus-induced polypeptides, J. Virol. 26:686–701 (1978).
Stinski, M. F., E. S. Mocarski, D. R. Thomsen, and M. L. Urbanowski, Membrane glycoproteins and antigens induced by human cytomegalovirus, J. Gen. Virol. 43:119– 129 (1979).
The, T. H., and M. M. A. C. Langenhuysen, Antibodies against membrane antigens of cytomegalovirus infected cells in sera of patients with a cytomegalovirus infection, Clin. Exp. Immunol. 11:475–482 (1972).
Kim, K. S., V. J. Sapienza, G.-M. J. Chen, and K. Wisniewski, Production and characterization of monoclonal antibodies specific for a glycosylated polypeptide of human cytomegalovirus, J. Clin. Microbiol. 18:331–343 (1983).
Kim, K. S., H. M. Moon, V. Sapienza, and R. I. Carp, Complement-fixing antigen of human cytomegaloviruses, J. Infect. Dis. 135:281–288 (1977).
Pereira, L., M., Hoffman, D. Gallo, and N. Cremer, Monoclonal antibodies to human cytomegalovirus: Three surface membrane proteins with unique immunological and electrophoretic properties specify cross-reactive determinants, Infect. Immun. 36:924– 932 (1982).
Pereira, L.,T.. Hoffman, M. Tatsuno, and D. Dondero, Polymorphism of human cytomegalovirus glycoproteins characterized by monoclonal antibodies, Virolgy 139:73–86 (1984).
Nowak, B., C. Sullivan, P. Sarnow, R. Thomas, F. Bricout, J. C. Nicolas, B. Fleckenstein, and A. J. Levine, Characterization of monoclonal antibodies and polyclonal immune sera directed against human cytomegalovirus virion proteins, Virology 132:325–338 (1984).
Rasmussen, L. E., R. M. Nelson, D. C. Kelsall, and T. C. Merigan, Murine monoclonal antibody to a single protein neutralizes the infectivity of human cytomegalovirus, Proc. Natl. Acad. Sci. U.S.A. 81:876–880 (1984).
Rasmussen, L., J. Mullenax, R. Nelson, and T. C. Merigan, Viral polypeptides detected by a complement-dependent neutralizing murine monoclonal antibody to human cytomegalovirus, J. Virol. 55:274–280 (1985).
Britt, W. J., Neutralizing antibodies detect a disulfìde-linked glycoprotein complex with in the envelope of human cytomegalovirus, Virology ,135:369–378 (1984).
Britt, W. J., and D. Auger, Synthesis and processing of the envelope gp 55–116 complex of human cytomegalovirus, J. Virol. 58:185–191 (1986).
Furukawa, T., E., Hornberger, S. Sakuma, and S. A. Plotkin, Demonstration of immunoglobulin G receptors induced by human cytomegalovirus, J. Clin. Microbiol. 2:332– 336 (1975).
Westmoreland, D., S. St. Jeor, and F. Rapp, The development of cytomegalovirus infected cells binding affinity for normal human immunoglobulin, J. Immunol. 116:1566– 1570 (1976).
Osborn, J. E., and D. N. Medearis, Jr., Suppression of interferon and antibody and multiplication of Newcastle disease virus in cytomegalovirus infected mice, Proc. Soc. Exp. Biol. Med. 124:347–353 (1967).
Osborn, J. E., A. A. Blazkovec, and D. L. Walker, Immunosuppression during acute murine cytomegalovirus infection, J. Immunol. 100:835–844 (1968).
Waner, J. L., Partial characterization of a soluble antigen preparation from cells infected with human cytomegalovirus: Properties of antisera prepared to the antigen, J. Immunol. 114:1454–1457 (1975).
Pereira, L., M., Hoffman, and N. Cremer, Electrophoretic analysis of polypeptides immune precipitated from cytomegalovirus-infected cell extracts by human sera, Infect. Immun. 36:933–942 (1982).
Cremer, N. E., M. Hoffman, and E. H. Lennette, Analysis of antibody assay methods and classes of viral antibodies in serodiagnosis of cytomegalovirus infection, /. Clin. Microbiol. 8:153–159 (1978).
Waner, J. L., T. H. Weller, and S. V. Kevy, Patterns of cytomegalovirus complement-fixing antibody activity: A longitudinal study of blood donors, J. Infect. Dis. 127:538–543 (1973).
Linde, G. A., L. Hammarstrom, M. A. A. Persson, C. I. E. Smith, V.-A. Sundqvist, and B. Wahren, Virus-specific antibody activity of different subclasses of immunoglobulins G and A in cytomegalovirus infections, Infect. Immun. 42:237–244 (1983).
Pereira, L., S. Stagno, M. Hoffman, and J. E. Volanakis, Cytomegalovirus-infected cell polypeptides immuneprecipitated by sera from children with congenital and perinatal infections, Infect. Immun. 39:100–108 (1983).
Waner, J. L., D. R. Hopkins, T. H. Weller, and E. N. Allred, Cervical excretion of cytomegalovirus: Correlation with secretory and humoral antibody. J. Infect. Dis. 136:805–809 (1977).
Tamura, T., S. Chiba, Y. Chiba, and T. Nakao, Virus excretion and neutralizing antibody response in saliva in human cytomegalovirus infection. Infect. Immun. 29:842–845 (1980a).
van Loon, A. M., J. T. M. van der Logt, F. W. A. Heessen, and J. van der Veen, Quantitation of immunoglobulin E antibody to cytomegalovirus by antibody capture enzyme-linked immunosorbent assay, J. Clin. Microbiol. 21:558–561 (1985).
Weller, T. H., J. B. Hanshaw, and D. E. Scott, Serologic differentiation of viruses responsible for cytomegalic inclusion disease, Virology 12:130–132 (1960).
Rundell, B. B., and R. F. Betts, Interaction of cytomegalovirus immune complexes with host cells, Infect Immun. 3:658–665 (1981).
Betts, R. F., and B. B. Rundell, Physical properties of cytomegalovirus immune complexes prepared with IgG neutralizing antibody anti-IgG, and complement, J. Immunol. 124:337–342 (1980).
Middledorp, J. M., J. Jongsma, and T. H. The, Immunity to human cytomegalovirus (HCMV). II. Latently-infected donors have high levels ot T cell memory to HCMV-specifíc membrane antigens (CMV-MA) in the absence of detectable antibodies to CMV-MA, in: CMV: Pathogenesis and Prevention of Human Infection (S. A. Plotkin, S. Michelson, J. S. Pagano, and F. Rapp, eds.), pp. 445–449, Liss, New York (1984).
Betts, R. F., and S. G. Schmidt, Cytolytic IgM antibody to cytomegalovirus to primary cytomegalovirus infection in humans, J. Infect. Dis. 143:821–826 (1981).
Middeldorp, J. M., J. Jongsma, and T. H. The, Killing of human cytomegalovirus-infected fibroblasts by antiviral antibody and complement, J. Infect. Dis. 153:48–55 (1986).
Middeldorp, J. M., J. Jongsma, and T. H. The, Cytomegalovirus early and late membrane antigens detected by antibodies in human convalescent sera, J. Virol. 54:240–244 (1985).
Stagno, S., J. E. Volanakis, D. W. Reynolds, R. Stroud, and C. A. Alford, Jr., Immune complexes in congenital and natal cytomegalovirus infections of man, /. Clin. Invest. 60:838–845 (1977).
Condie, R. M., B. L. Hall, and R.J. Howard, Treatment of life threatening infections in renal transplant recipients with high dose intravenous human IgG, Transplant Proc. 11:66–72 (1979).
Winston, D. J., R. B. Pollard, W. G. Ho, J. G. Gallagher, L. E. Rasmussan, S. N.-Y. Huang, C.-H. Lin, T. G. Gossett, T. C. Merigan, and R. P. Gala, Cytomegalovirus immune plasma in bone marrow transplant recipients, Ann. Intern. Med. 97:11 18 (1982).
Myers, J. D., J. Lesczynski, J. A. Zaia, N. Flournoy, B. Newton, D. R. Szydman, G. G. Wright, M. J. Levin, and E. D. Thomas, Prevention of cytomegalovirus infection by cytomegalovirus immune globulin after marrow transplantation, Ann. Intern. Med. 98:442–446 (1983).
Condie, R. M., and R.J. O’Reilly, Prevention of cytomegalovirus infection by prophylaxis with an intravenous, hyperimmune, native, unmodified cytomegalovirus globulin. Randomized trial in bone marrow transplant recipients, Am. J. Med. 76:(3A):124–141 (1984).
Møller-Larsen, A., H. K. Anderson, I. Heron, and I. Sarov, In vitro stimulation of human lymphocytes by purified CMV, Intervirology 6:249–257 (1975/76).
Ten Napel, C. H. H., T. H. The, J. Bijker, G. C. DeGast, and M. M. A. C. Langenhuysen, Cytomegalovirus-directed lymphocyte reactivity in healthy adults tested by a cytomega-lovirus-induced lymphocyte transformation test, Clin. Exp. Immuno. 29:52–60 (1977).
Waner, J. L., and J. E. Budnick, Blastogenic response of human lymphocytes to human cytomegalovirus, Clin. Exp. Immuno. 30:44–49 (1977).
Wahren, B., K.-H. Robert, and S. Nordlund, Conditions for cytomegalovirus stimulation of lymphocytes, Scand. J. Immunol. 13:581–586 (1981).
Schirm, J., H. W. Roenhorst, and T. H. The, Comparison of in vitro lymphocyte proliferations induced by cytomegalovirus-infected human fibroblasts and cell-free cytomegalovirus, Infect. Immun. 30:621–627 (1980).
Roenhorst, H. W., J. M. Middledorp, J. M. Beelen, J. Schirm, A. M. Tegzess, and T. H. The, Maintenance of cytomegalovirus (CMV) latency and host immune responses of long-term renal allograft survivors. I. Prolonged suppression of in vitro lymphocyte responses against CMV infected fibroblasts related to previous secondary CMV infection, Clin. Exp. Immunol. 59:709–715 (1985).
Beutner, K. R., A. Morag, R. Deibel, B. Morag, D. Raiken, and P. L. Ogra, Strain-specific local and systemic cell-mediated immune responses to cytomegalovirus in humans, Infect. Immun. 20:82–87 (1978).
Starr, S. E., B. Dalton, T. Garrabrant, K. Paucker, and S. A. Plotkin, Lymphocyte blastogenesis and interferon production in adult human leukocyte cultures stimulated with cytomegalovirus antigens, Infect. Immun. 30:17–22 (1980).
Ten Napel, C. H. H., and T. H. The, Acute cytomegalovirus infection and the host immune response. I. Development and maintenance of cytomegalovirus induced in vitro lymphocyte reactivity and its relationship to production of cytomegalovirus antibodies, Clin. Exp. Immunol. 39:263–271 (1980).
Waner, J. L., N. Kong, and S. Biano, Blastogenic response of human lympho cytes to early antigen(s) of human cytomegalovirus, Infect. Immun. 41:1084–1088 (1983).
Rinaldo, C. R., Jr., P. H. Black, and M. S. Hirsch, Interactions of cytomegalovirus with leukocytes from patients with mononucleosis due to cytomegalovirus, J. Infect. Dis. 136:667–678 (1977).
Carney, W. P., R. H. Rubin, R. A. Hoffman, W. P. Hansen, K. Healey, and M. S. Hirsch, Analysis of T lymphocyte subsets in cytomegalovirus mononucleosis, J. Immunol. 126:2114–2116 (1981).
Levin, M. J., C. R. Rinaldo, Jr., P. L. Leary, J. A. Zaia, and M. S. Hirsch, Immune response to herpesvirus antigens in adults with acute cytomegaloviral mononucleosis, J. Infect. Dis. 140:851–857 (1979).
Gehrz, R. C., S. C. Marker, S. O. Knorr, J. M. Kalis, and H. H. Balfour, Jr., Specific cell-mediated immune defect in active cytomegalovirus infection of young children and their mothers, Lancet 2:844–847 (1977).
Gehrz, R. C., W. R. Christianson, K. M. Linner, M. M. Conroy, S. A. McCue, and H. H. Balfour, Jr., Cytomegalovirus-specifìc humoral and cellular immune responses in human pregnancy, J. Infect. Dis 143:391–395 (1981).
Faix, R. G., S. E. Zweig, J. F. Kummer, D. Moore, and D. J. Lang, Cytomegalovirus-specifìc cell-mediated immunity during pregnancy in lower socioeconomic class adolescents,/ Infect. Dis. 148:621–629 (1983).
Diamond, R. D., R. Keller, G. Lee, and D. Finkel, Lysis of cytomegalovirus-infected human fibroblasts and transformed human cells by peripheral blood-lymphoid cells from normal human donors, Proc. Soc. Exp. Biol. Med. 154:259–364 (1977).
Kirmani, N., R. K. Ginn, K. K. Mittal, J. F. Manischewitz, and G. V. Quinnan, Jr., Cytomegalovirus-specifìc cytotoxicity mediated by non-T lymphocytes from peripheral blood of normal volunteers, Infect. Immun. 34:441–447 (1981).
Starr, S. E., and T. Garrabrant, Natural killing of cytomegalovirus-infected fibroblasts by human mononuclear leukocytes, Clin. Exp. Immunol. 46:484–492 (1981).
Waner, J. L., and J. A. Nierenberg, Natural killing (NK) of cytomegalovirus (CMV)-infected fibroblasts: A comparison between two strains of CMV, uninfected fibroblasts and K562 cells, J Med. Virol. 16:233–244 (1985).
Borysiewicz, L. K., B. Rodgers, S. Morris, S. Graham, and J. G. P. Sissons, Lysis of human cytomegalovirus infected fibroblasts by natural killer cells: Demonstration of an interferon-independent component requiring expression of early viral proteins and characterization of effector cells, J. Immunol. 134:2695–2701 (1985).
Rola-Pleszczynski, M., L. D. Frenkel, D. A. Fuccillo, S. A. Hensen, M. M. Vincent, D. W. Reynolds, S. Stagno, and J. A. Bellanti, Specific impairment of cell-mediated immunity in mothers of infants with congenital infection due to cytomegalovirus, J Infect Dis. 135:386–391 (1977).
Harrison, C. J., and J. L. Waner, Natural killer cell activity in infants and children excreting cytomegalovirus, J. Infect. Dis. 151:301–307 (1985).
Starr, S. E., L. Smiley, C. Wlodaver, H. M. Friedman, S. A. Plotkin, and C. Barker, Natural killing of cytomegalovirus-infected targets in renal transplant recipients, Transplantation 37:161–164 (1984).
Rinaldo, C. R., Jr., M. Ho, W. H. Hamoudi, X.-E. Gui, and R. L. DeBiasio, Lymphocyte subsets and natural killer cell responses during cytomegalovirus mononucleosis, Infect. Immun. 40:472–477 (1983).
Quinnan, G. V., Jr., N. Kirmani, A. H. Rook, J. F. Manischewitz, L.Jackson, G. Moreschi, G. W. Santos, R. Saral, and W. B. Burns, HLA-restricted T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipients, N. Engl. J. Med. 307:7–13 (1982).
Quinnan, G. V., and J. E. Manischewitz, The role of natural killer cells and antibody dependent cell-mediated cytotoxicity during murine cytomegalovirus infection, J. Exp. Med. 150:1549–1554 (1979).
Bukowski, J. F., B. A. Woda, and R. M. Welsh, Pathogenesis of murine cytomegalovirus infection in natural killer cell-depleted mice, J. Virol. 52:119–128 (1984).
Selgrade, M. K., and J. E. Osborn, Role of macrophages in resistance to murine cytomegalovirus, Infect. Immun. 10:1383–1390 (1974).
Chalmer, J. E., J. S. Mackenzie, and N. F. Stanley, Resistance to murine cytomegalovirus linked to the major histocompatibility complex of the mouse, J. Gen. Virol. 37:107–114 (1977).
Bancroft, G. J., G. R. Shellam, and J. E. Chalmer, Genetic influences on the augmenta tion of natural killer (NK) cells during murine cytomegalovirus infection: Correlation with patterns of resistance, J. Immunol. 126:988–994 (1981).
Shellam, G. R., J. E. Allan, J. M. Papadimitriou, and G. J. Bancroft, Increased susceptibility to cytomegalovirus infection in beige mutant mice, Proc. Natl. Acad. Sci. USA 78:5104–5108 (1981).
Kay, H. D., G. D. Bonnard, W. H. West, and R. B. Herberman, A functional comparison of human Fc-receptor bearing lymphocytes active in natural cytotoxicity and antibody-dependent cellular cytotoxicity, J. Immunol. 118:2058–2066 (1977).
Quinnan, G. V., N. Kirmani, E. Esber, R. Saral, J. E. Manischewitz, J. L. Rogers, A. H. Rook, G. W. Santos, and W. H. Burns, HLA-restricted cytotoxic T lymphocyte and non-thymic cytotoxic lymphocyte responses to cytomegalovirus infections of bone marrow transplant recipients, J. Immunol. 126:2036–2041 (1981).
Borysiewicz, L. K., S. Morris, J. D. Page, and J. G. P. Sissons, Human cytomegalovirus-specific cytotoxic T lymphocytes: Requirements for in vitro generation and specificity, Eur. J. Immunol. 13:804–809 (1983).
Gehrz, R. C., and S. R. Rutzick, Cytomegalovirus (CMV)-specific lysis of CMV-infected target cells can be mediated by both NK-like and virus-specific cytotoxic T lymphocytes, Clin. Exp. Immunol. 61:80–89 (1985).
Quinnan, G. V., Jr., W. H. Burns, N. Kirmani, A. H. Rook,J. Manischewitz, L.Jackson, G. W. Santos, and R. Saral, HLA-restricted cytotoxic T lymphocytes are an early immune response and important defense mechanism in cytomegalovirus infections, Rev. Infect. Dis. 6:156–163 (1984).
Rook, A. H., G. V. Quinnan, Jr., W. J. R. Fredericks. F. Manischewitz, and N. Kirmani, Importance of cytotoxic lymphocytes during cytomegalovirus infection in renal transplant recipients, Am. J. Med. 76:385–392 (1984).
Felsenstein, D., W. P. Carney, V. R. Iacoviello, and M. S. Hirsch, Phenotypic properties of atypical lymphocytes in cytomegalovirus-induced mononucleosis, J. Infect. Dis. 152:198–203 (1985).
Maher, P., C. M. O’Toole, T. G. Wreghitt, D. J. Spiegelhalter, and T. A. H. English, Cytomegalovirus infection in cardiac transplant recipients associated with chronic T cell subset ratio inversion with expansion of Leu-7 + Ts_c+ subset, Clin. Exp. Immunol. 62:615–624 (1985).
Pass, R. F., M. A. Roper, and A. M. August, T lymphocyte subpopulations in congenital cytomegalovirus infection, Infect. Immun. 41:1380–1382 (1983).
Fiala, M., J. E. Payne, T. V. Berne, T. C. Moore, W. Henle, J. Z. Montgomerie, S. N. Chatterjee, and L. B. Guze, Epidemiology of cytomegalovirus infection after transplan tation and immunosuppression, J. Infect. Dis. 132:421–433 (1975).
Winston, D. J., W. G. Ho, C. L. Howell, M. J. Miller, R. Mickey, W. J. Martin, C. Lin, and R. P. Gale, Cytomegalovirus infections associated with leukocyte transfusions. Ann. Intern. Med. 93:671–675 (1980).
Diosi, P., E. Moldovan, and N. Tomescu, Latent cytomegalovirus infection in blood donors, Br. Med. J. 4:660–662 (1969).
Schrier, R. D., J. A. Nelson, and M. B. A. Oldstone, Detection of human cytomegalovirus in peripheral blood lymphocytes in a natural infection, Science 230:1048–1051 (1985).
St. Jeor, S., and A. Weisser, Persistence of cytomegalovirus in human lymphoblasts and peripheral leukocyte cultures, Infect. Immun. 15:402–409 (1977).
Furukawa, T., N. Yoshimura, J. H. Jean, and S. A. Plotkin, Chronically persistent infection with human cytomegalovirus in human lymphoblasts, J. Infect. Dis. 139:211–214 (1979).
Tocci, M. J., and S. C. St. Jeor, Susceptibility of lymphoblastoid cells to infection with human cytomegalovirus, Infect. Immun. 23:418–423 (1979).
Tocci, M. J., and S. C. St. Jeor, Persistence and replication of the human cytomegalovirus genome in lymphoblastoid cells of B and T origin, Virology 96:664–668 (1979).
Einhorn, L., and A. Ost, Cytomegalovirus infection of human blood cells, J. Infect. Dis. 149:207–214 (1984).
Rice, G. P. A., R. D. Schrier, and M. B. A. Oldstone, Cytomegalovirus infects human lymphocytes and monocytes: Virus expression is restricted to immediate-early gene products, Proc. Natl. Acad. Sci. USA 81:6134–6138 (1984).
Sing, G. K., and H. M. Garnett, The effects of human cytomegalovirus challenge in vitro on subpopulations of T cells from seronegative donors, J. Med. Virol 14:363–371 (1984).
Hutt-Fletcher, L. M., N. Balachandran, and M. H. Elkins, B cell activation by cytomegalovirus, J. Exp. Med. 158:2171–2176 (1983).
Yachie, A., G. Tosato, S. E. Straus, and R. M. Blaese, Immunostimulation by cytomegalovirus (CMV): Helper T cell-dependent activation of immunoglobulin production in vitro by lymphocytes from CMV-immune donors, J. Immunol. 135:1395–1400 (1985).
Rinaldo, C. R., Jr., W. P. Carney, B. S. Richter, P. H. Black, and M. S. Hirsch, Mechanisms of immunosuppression in cytomegaioviral mononucleosis, J. Infect. Dis. 141:488–495 (1980).
Carney, W. P., and M. S. Hirsch, Mechanisms of immunosuppression in cytomegalovirus mononucleosis. II. Virus-monocyte interactions, J. Infect. Dis. 144: 47–54 (1981).
Rodgers, B. C., D. M. Scott, J. Mundin, and J. G. P. Sissons, Monocyte-derived inhibitor of interleukin 1 induced by human cytomegalovirus, J. Virol. 55: 527–532 (1985).
Drew, W. L., M. A. Conant, R. C. Miner, E. S. Huang, J. L. Ziegler, J. R. Groundwater, J. H. Gullett, P. Volberding, D. I. Abrams, and L. Mintz, Cytomegalovirus and Kaposis sarcoma in young homosexual men, Lancet 2:125–127 (1982).
Macher, A. M., C. M. Reichert, S. E. Straus, D. L. Longo, J. Parrillo, H. C. Lane, and A. S. Fauci, Death in the AIDS patient: Role of cytomegalovirus, (Letter.) N. Engl. J. Med. 309:1454 (1983).
Quinnan, G. V. Jr., H. Masur, A. H. Rook, G. Armstrong, W. R. Fredericks. Epstein, J. F. Manischewitz, A. M. Macher, L. Jackson, J. Ames, H. A. Smith, M. Parker, G. R. Pearson, J. Parrillo, C. Mitchell, and S. E. Straus, Herpesvirus infections in the acquired immune deficiency syndrome, JAMA 252:72–77 (1984).
Hirsch, M. S., R. T. Schooley, D. D. Ho, and J. C. Kaplan, Possible viral interactions in the acquired immunodeficiency syndrome (AIDS), Rev. Infect. Dis. 6:726–731 (1984).
Kari, B., N. Lussenhop, R. Goertz, M. Wabuke-Bunoti, R. Radeke, and R. Gehrz, Characterization of monoclonal antibodies reactive to several biochemically distinct human cytomegalovirus glycoprotein complexes, J. Virol. 60:345–352 (1986).
Cranage, M. P., T. Kouzarides, A. T. Bankier, S. Satchwell, K. Weston, P. Tomlinson, B. Barrell, H. Hart, S. E. Bell, A. C. Minson, and G. L. Smith, Identification of the human cytomegalovirus glycoprotein B gene and induction of neutralizing antibodies via its expression in recombinant vaccinia virus, EMBO. 5:3057–3063 (1986).
Gold, D., R. Ashley, H. H. Handsfield, M. Verdon, L. Leach, J. Mills, L. Drew, and L. Corey, Immunoblot analysis of the humoral immune response in primary cytomegalovi rus infection, J Infect. Dis. 157:319–326 (1988).
Zaia, J., S. J. Forman, Y-P. Ting, E. Vanderwal-Urbina, and K. G. Blume. Polypeptide-specific antibody response to human cytomegalovirus after infection in bone marrow transplant recipients, J. Infect Dis. 153:780–787 (1986).
Schrier, R. D., and M. B. A. Oldstone, Recent clinical isolates of cytomegalovirus suppress human cytomegalovirus-specific human leukocyte antigen-restricted cytotoxic T-lymphocyte activity, J. Virol. 59:127–131 (1986).
Braun, R. W., and H. C. Reiser, Replication of human cytomegalovirus in human peripheral blood T cells, J. Virol. 60:29–36 (1986).
Dudding, L. R., and H. M. Garnett, Interaction of strain AD 169 and a clinical isolate of cytomegalovirus with peripheral monocytes: The effect of lipopolysaccharide stimulation, J. Infect. Dis. 155:891–896 (1987).
Weinshenker, B. G., W. Sharon, and G. P. A. Rice, Phorbol ester-induced differentiation permits productive human cytomegalovirus infection in a monocyte cell line, J. Immunol. 140:1625–1631 (1988).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Plenum Press, New York
About this chapter
Cite this chapter
Waner, J.L. (1989). Human Cytomegalovirus. In: Specter, S., Bendinelli, M., Friedman, H. (eds) Virus-Induced Immunosuppression. Infectious agents and pathogenesis. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5583-0_6
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5583-0_6
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5585-4
Online ISBN: 978-1-4684-5583-0
eBook Packages: Springer Book Archive